Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Glucokinase Drugs in Development Report Overview
The role of Glucokinase is to provide G6P for the synthesis of glycogen. Pancreatic glucokinase plays an important role in modulating insulin secretion while hepatic glucokinase helps to facilitate the uptake and conversion of glucose by acting as an insulin-sensitive determinant of hepatic glucose usage.
Key Therapy Areas | Metabolic Disorders, Central Nervous System, Gastrointestinal, and Infectious Diseases |
Key Mechanisms of Action | Glucokinase Activator |
Key Routes of Administration | Oral and Intramuscular |
Key Molecule Type | Small Molecule, Gene Therapy, Peptide, and Recombinant Protein |
Leading players | AstraZeneca Plc, Eli Lilly and Co, Hua Medicine Shanghai Ltd, Impetis Biosciences Ltd, Kriya Therapeutics Inc, Ligand Pharmaceuticals Inc, Merck & Co Inc, Pfizer Inc, Sanwa Kagaku Kenkyusho Co Ltd, and vTv Therapeutics Inc |
The Glucokinase pipeline market research report provides comprehensive information on the Glucokinase targeted therapeutics. It offers complete analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research, and development history as well as the latest news and press releases. Additionally, the report provides an overview of key players involved in Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted therapeutics development with respective active and dormant or discontinued projects.
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close to 21 molecules. Report covers products from therapy areas Metabolic Disorders, Central Nervous System, Gastrointestinal and Infectious Disease which include indications Type 2 Diabetes, Type 1 Diabetes (Juvenile Diabetes), Alzheimer’s Disease, Coronavirus Disease 2019 (COVID-19), Diabetes, Diabetic Nephropathy, Non-Alcoholic Steatohepatitis (NASH), Obesity and Unspecified Metabolic Disorders.
Glucokinase Pipeline Products Market Segmentation by Therapy Areas
The key therapy areas in the Glucokinase pipeline products market are metabolic disorders, central nervous system, gastrointestinal, and infectious diseases.
Glucokinase Pipeline Products Market Analysis by Therapy Areas, 2022 (%)For more therapy area insights into the Glucokinase pipeline products market, download a free report sample
Glucokinase Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanism of action in the Glucokinase pipeline products market is Glucokinase Activator.
Glucokinase Pipeline Products Market Segmentation by Routes of Administration
The key routes of administration in the Glucokinase pipeline products market are oral and intramuscular.
Glucokinase Pipeline Products Market Analysis by Routes of Administration, 2022 (%)
For more routes of administration insights into the Glucokinase pipeline products market, download a free report sample
Glucokinase Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Glucokinase pipeline products market are small molecule, gene therapy, peptide, and recombinant protein.
Glucokinase Pipeline Products Market Analysis by Molecule Types, 2022 (%)
For more molecule type insights into the Glucokinase pipeline products market, download a free report sample
Competitive Landscape
The leading players in the Glucokinase pipeline products market are AstraZeneca Plc, Eli Lilly and Co, Hua Medicine Shanghai Ltd, Impetis Biosciences Ltd, Kriya Therapeutics Inc, Ligand Pharmaceuticals Inc, Merck & Co Inc, Pfizer Inc, Sanwa Kagaku Kenkyusho Co Ltd, and vTv Therapeutics Inc.
Glucokinase Pipeline Products Market Analysis by Companies, 2022 (%)
To know more about leading players in the Glucokinase pipeline products market, download a free report sample
Scope
- The report provides a snapshot of the global therapeutic landscape for Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2)
- The report reviews Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which include, product description, descriptive MoA, R&D brief, licensing, and collaboration details & other developmental activities
- The report reviews key players involved in Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted therapeutics and enlists all their major and minor projects
- The report assesses Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews the latest news and deals related to Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Eli Lilly and Co
Hua Medicine Shanghai Ltd
Impetis Biosciences Ltd
Kriya Therapeutics Inc
Ligand Pharmaceuticals Inc
Merck & Co Inc
Pfizer Inc
Sanwa Kagaku Kenkyusho Co Ltd
vTv Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the Glucokinase pipeline products market?
The key therapy areas in the Glucokinase pipeline products market are metabolic disorders, central nervous system, gastrointestinal, and infectious diseases.
-
What are the key mechanisms of action in the Glucokinase pipeline products market?
The key mechanism of action in the Glucokinase pipeline products market is Glucokinase Activator.
-
What are the key routes of administration in the Glucokinase pipeline products market?
The key routes of administration in the Glucokinase pipeline products market are oral and intramuscular.
-
What are the key molecule types in the Glucokinase pipeline products market?
The key molecule types in the Glucokinase pipeline products market are small molecule, gene therapy, peptide, and recombinant protein.
-
Who are the leading players in the Glucokinase pipeline products market?
The leading players in the Glucokinase pipeline products market are AstraZeneca Plc, Eli Lilly and Co, Hua Medicine Shanghai Ltd, Impetis Biosciences Ltd, Kriya Therapeutics Inc, Ligand Pharmaceuticals Inc, Merck & Co Inc, Pfizer Inc, Sanwa Kagaku Kenkyusho Co Ltd, and vTv Therapeutics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.